How does HIV PrEP work, and who is eligible for it in Europe?

HIV PrEP explained: pre-exposure prophylaxis, tenofovir/emtricitabine, prevention efficacy, eligibility criteria, and medical monitoring.

In this episode, we outline how HIV pre-exposure prophylaxis (PrEP) reduces the risk of HIV transmission and how doctors assess suitability under EU clinical guidance.

You’ll learn:

• What PrEP is (daily or event-based antiviral medication taken before exposure)

• How tenofovir and emtricitabine block HIV replication

• Who is considered eligible (higher-risk sexual exposure, HIV-negative status confirmed)

• The difference between daily PrEP and on-demand dosing

• The importance of regular HIV testing and kidney function monitoring

• Why PrEP does not protect against oth ...